Biofrontera AG IPO Research Information

Biofrontera AG IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Biofrontera AG, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Biofrontera AG	BFRA - NASDAQ	$11.00-$13.00	$9.88	$13.00	1.21 million	2/14/2018
Underwriter(s): Benchmark
Co-Manager(s): Dawson James Securities, Lake Street Capital Markets
Industry: Health Care
Filing(s): Updated Prospectus 2018-01-31 Filed 2018-01-12 Terms Added 2018-01-26 Updated Terms 2018-02-13 Final Prospectus 2018-02-15

Biofrontera AG Quote & Chart - Click for current quote - BFRA

About Biofrontera AG (adapted from Biofrontera AG prospectus):
They are an international biopharmaceutical company specializing in the development and commercialization of a platform of pharmaceutical products for the treatment of dermatological conditions and diseases caused primarily by exposure to sunlight that results in sun damage to the skin. $15 million cash raise listed.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "BFRA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.